Case 1: Guidelines for HER2 Testing in Breast Cancer

#BREASTPATH Destiny of HER2/neu in the era of HER2-low in 2024Подробнее

HER2 Testing in Breast Cancer: Improving IHC PerformanceПодробнее

New Perspectives on the Full Spectrum of HER2 Expression in Breast CancerПодробнее

Evolving and Emerging Trends in HER2 Classification and Reporting in Breast CancerПодробнее

How Metastatic Brain Tumors Affect Your Breast Cancer CareПодробнее

Optimizing Treatment Options for HER2+/ ER+ Breast Cancer using Models of Endocrine ResistanceПодробнее

Case 1: When to Use FISH Testing in Breast CancerПодробнее

Breast cancer Case 1: pregnancy; Case 2: diagnostics; case 3: Her2 testing; Case 4: receptorsПодробнее

Updates in HER2 Testing in Breast CancerПодробнее

HER2 IHC Interpretation Guide (Examples and Challenging Scenarios)Подробнее